CE
Therapeutic Areas
Sprout Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Addyi (flibanserin) | Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women | Approved |
| Drug | Indication | Phase |
|---|---|---|
| Addyi (flibanserin) | Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women | Approved |